Enhancing Antitumor Immunity of FasL-Transfected Lewis Lung Carcinoma Is Used by Dendritic Cell-Based Vaccine
碩士 === 國立臺灣海洋大學 === 生物科技研究所 === 92 === Abstract The malignant tumor is a serious disease in human today. Conventional treatments for it include surgery, chemotherapy, and radiation therapy used alone or in combination. Despite the increasingly intense application and continuous modification of thes...
Main Authors: | Yi-Lin Tsai, 蔡一麟 |
---|---|
Other Authors: | Shye-Jye Tang |
Format: | Others |
Language: | zh-TW |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/38866978641976551875 |
Similar Items
-
The antitumor immunity of FasL-transfected Lewis lung carcinoma enhanced by cyclooxygenase-2 inhibitor
by: Ren-Shiang Jhou, et al.
Published: (2004) -
Induction of antitumor immunity with injection of Fas Ligand (CD95L )-transfected Lewis lung carcinoma in mice
by: 朱嘉憶
Published: (2002) -
Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling
by: Jiabin Yan, et al.
Published: (2015-03-01) -
FAS AND FASL EXPRESSION IN MAMMARY CARCINOMAS
by: Dorina Munteanu, et al.
Published: (2004-08-01) -
Apoptosis and Fas/FasL Pathway: role of FAS and FASL Functional Polymorphisms in Prostate Cancer development
by: Lima, Luís Carlos Oliveira
Published: (2011)